{"creationDateTime": "2023-08-11T09:43:34", "datasetJSONVersion": "1.0.0", "fileOID": "www.cdisc.org/StudyMSGv2/1/Define-XML_2.1.0.TS", "originator": "CDISC MSG Team", "referenceData": {"studyOID": "cdisc.com/CDISCPILOT01", "metaDataVersionOID": "MDV.MSGv2.0.SDTMIG.3.3.SDTM.1.7", "itemGroupData": {"TS": {"records": 51, "name": "TS", "label": "Trial Summary", "items": [{"OID": "ITEMGROUPDATASEQ", "name": "ITEMGROUPDATASEQ", "label": "Record identifier", "type": "integer"}, {"OID": "IT.TS.STUDYID", "name": "STUDYID", "label": "Study Identifier", "type": "string", "length": 12, "keySequence": 1}, {"OID": "IT.TS.DOMAIN", "name": "DOMAIN", "label": "Domain Abbreviation", "type": "string", "length": 2}, {"OID": "IT.TS.TSSEQ", "name": "TSSEQ", "label": "Sequence Number", "type": "integer", "length": 3, "keySequence": 4}, {"OID": "IT.TS.TSGRPID", "name": "TSGRPID", "label": "Group ID", "type": "string", "length": 200}, {"OID": "IT.TS.TSPARMCD", "name": "TSPARMCD", "label": "Trial Summary Parameter Short Name", "type": "string", "length": 8, "keySequence": 2}, {"OID": "IT.TS.TSPARM", "name": "TSPARM", "label": "Trial Summary Parameter", "type": "string", "length": 40}, {"OID": "IT.TS.TSVAL", "name": "TSVAL", "label": "Parameter Value", "type": "string", "length": 200, "keySequence": 3}, {"OID": "IT.TS.TSVALNF", "name": "TSVALNF", "label": "Parameter Null Flavor", "type": "string", "length": 4}, {"OID": "IT.TS.TSVALCD", "name": "TSVALCD", "label": "Parameter Value Code", "type": "string", "length": 200}, {"OID": "IT.TS.TSVCDREF", "name": "TSVCDREF", "label": "Name of the Reference Terminology", "type": "string", "length": 200}, {"OID": "IT.TS.TSVCDVER", "name": "TSVCDVER", "label": "Version of the Reference Terminology", "type": "string", "length": 200}], "itemData": [[1, "CDISCPILOT01", "TS", 1, "", "ACTSUB", "Actual Number of Subjects", "18", "", "", "", ""], [2, "CDISCPILOT01", "TS", 1, "", "ADAPT", "Adaptive Design", "N", "", "C49487", "CDISC", "2020-03-27"], [3, "CDISCPILOT01", "TS", 1, "", "ADDON", "Added on to Existing Treatments", "N", "", "C49487", "CDISC", "2020-03-27"], [4, "CDISCPILOT01", "TS", 1, "", "AGEMAX", "Planned Maximum Age of Subjects", "", "PINF", "", "", ""], [5, "CDISCPILOT01", "TS", 1, "", "AGEMIN", "Planned Minimum Age of Subjects", "P50Y", "", "", "ISO 8601", ""], [6, "CDISCPILOT01", "TS", 1, "CUTOFF", "DCUTDESC", "Data Cutoff Description", "DATABASE LOCK", "", "", "", ""], [7, "CDISCPILOT01", "TS", 1, "CUTOFF", "DCUTDTC", "Data Cutoff Date", "2015-03-31", "", "", "ISO 8601", ""], [8, "CDISCPILOT01", "TS", 1, "PLACEBO", "DOSE", "Dose per Administration", "0", "", "", "", ""], [9, "CDISCPILOT01", "TS", 2, "LOW-DOSE", "DOSE", "Dose per Administration", "54", "", "", "", ""], [10, "CDISCPILOT01", "TS", 3, "HIGH-DOSE", "DOSE", "Dose per Administration", "54", "", "", "", ""], [11, "CDISCPILOT01", "TS", 4, "HIGH-DOSE", "DOSE", "Dose per Administration", "81", "", "", "", ""], [12, "CDISCPILOT01", "TS", 1, "", "DOSFRM", "Dose Form", "INJECTION", "", "C42946", "CDISC", "2020-03-27"], [13, "CDISCPILOT01", "TS", 1, "", "DOSFRQ", "Dosing Frequency", "QD", "", "C25473", "CDISC", "2020-03-27"], [14, "CDISCPILOT01", "TS", 1, "", "DOSU", "Dose Units", "mg", "", "C28253", "CDISC", "2020-03-27"], [15, "CDISCPILOT01", "TS", 1, "", "FCNTRY", "Planned Country of Investigational Sites", "USA", "", "USA", "ISO 3166-1 alpha-3", ""], [16, "CDISCPILOT01", "TS", 1, "", "HLTSUBJI", "Healthy Subject Indicator", "N", "", "C49487", "CDISC", "2020-03-27"], [17, "CDISCPILOT01", "TS", 1, "", "INDIC", "Trial Disease/Condition Indication", "Alzheimer's Disease (Disorder)", "", "26929004", "SNOMED", "2019-03-01"], [18, "CDISCPILOT01", "TS", 1, "", "INTMODEL", "Intervention Model", "PARALLEL", "", "C82639", "CDISC", "2020-03-27"], [19, "CDISCPILOT01", "TS", 1, "", "INTTYPE", "Intervention Type", "DRUG", "", "C1909", "CDISC", "2020-03-27"], [20, "CDISCPILOT01", "TS", 1, "", "LENGTH", "Trial Length", "P28W", "", "", "ISO 8601", ""], [21, "CDISCPILOT01", "TS", 1, "", "NARMS", "Planned Number of Arms", "3", "", "", "", ""], [22, "CDISCPILOT01", "TS", 1, "EFFICACY", "OBJPRIM", "Trial Primary Objective", "To document the efficacy profile of Zanomaline.", "", "", "", ""], [23, "CDISCPILOT01", "TS", 2, "SAFETY", "OBJPRIM", "Trial Primary Objective", "To document the safety profile of Zanomaline.", "", "", "", ""], [24, "CDISCPILOT01", "TS", 1, "EFFICACY", "OUTMSPRI", "Primary Outcome Measure", "To assess the dose-dependent improvement in subject depression. Improved scores on the Patient Health Questionnaire(PHQ-9) and the Hamilton Depression Rating Scale(HAMD 17) will indicate improvements.", "", "", "", ""], [25, "CDISCPILOT01", "TS", 2, "EFFICACY", "OUTMSPRI", "Primary Outcome Measure", "To assess the dose-dependent improvements in satisfaction with subjects' lives as a whole. Improved scores on the Satisfaction With Life Survery (SWLS) will indicate improvements.", "", "", "", ""], [26, "CDISCPILOT01", "TS", 3, "EFFICACY", "OUTMSPRI", "Primary Outcome Measure", "To assess the dose-dependent improvements in subject memory and learning. Improved scores on the Auditory Verbal Learning Test (AVLT-REY) will indicate improvements.", "", "", "", ""], [27, "CDISCPILOT01", "TS", 4, "SAFETY", "OUTMSPRI", "Primary Outcome Measure", "Type, frequency, and severity of laboratory abnormalities", "", "", "", ""], [28, "CDISCPILOT01", "TS", 5, "SAFETY", "OUTMSPRI", "Primary Outcome Measure", "Type, frequency, and severity of adverse events (AEs)", "", "", "", ""], [29, "CDISCPILOT01", "TS", 1, "", "PCLAS", "Pharmacologic Class", "Acetylcholine Release Inhibitor", "", "N0000175771", "MED-RT", ""], [30, "CDISCPILOT01", "TS", 1, "", "PLANSUB", "Planned Number of Subjects", "20", "", "", "", ""], [31, "CDISCPILOT01", "TS", 1, "", "RANDOM", "Trial is Randomized", "Y", "", "C49488", "CDISC", "2020-03-27"], [32, "CDISCPILOT01", "TS", 1, "", "RANDQT", "Randomization Quotient", "0.67", "", "", "", ""], [33, "CDISCPILOT01", "TS", 1, "", "REGID", "Registry Identifier", "NCT00000000", "", "NCT00000000", "clinicaltrials.gov", ""], [34, "CDISCPILOT01", "TS", 1, "", "ROUTE", "Route of Administration", "SUBCUTANEOUS", "", "C38299", "CDISC", "2020-03-27"], [35, "CDISCPILOT01", "TS", 1, "", "SDTIGVER", "SDTM IG Version", "3.3", "", "", "", ""], [36, "CDISCPILOT01", "TS", 1, "", "SDTMVER", "SDTM Version", "1.7", "", "", "", ""], [37, "CDISCPILOT01", "TS", 1, "", "SENDTC", "Study End Date", "2014-11-01", "", "", "ISO 8601", ""], [38, "CDISCPILOT01", "TS", 1, "", "SEXPOP", "Sex of Participants", "BOTH", "", "C49636", "CDISC", "2020-03-27"], [39, "CDISCPILOT01", "TS", 1, "", "SPONSOR", "Clinical Study Sponsor", "SDTM Metadata Submission Guidelines Team", "", "", "", ""], [40, "CDISCPILOT01", "TS", 1, "", "SSTDTC", "Study Start Date", "2012-10-06", "", "", "ISO 8601", ""], [41, "CDISCPILOT01", "TS", 1, "", "STOPRULE", "Study Stop Rules", "NONE", "", "", "", ""], [42, "CDISCPILOT01", "TS", 1, "", "STYPE", "Study Type", "INTERVENTIONAL", "", "C98388", "CDISC", "2020-03-27"], [43, "CDISCPILOT01", "TS", 1, "", "TBLIND", "Trial Blinding Schema", "DOUBLE BLIND", "", "C15228", "CDISC", "2020-03-27"], [44, "CDISCPILOT01", "TS", 1, "", "TCNTRL", "Control Type", "PLACEBO", "", "C49648", "CDISC", "2020-03-27"], [45, "CDISCPILOT01", "TS", 1, "", "TDIGRP", "Diagnosis Group", "Patients with Probable Mild to Moderate Alzheimers Disease", "", "", "", ""], [46, "CDISCPILOT01", "TS", 1, "", "TINDTP", "Trial Intent Type", "TREATMENT", "", "C49656", "CDISC", "2020-03-27"], [47, "CDISCPILOT01", "TS", 1, "", "TITLE", "Trial Title", "Safety and Efficacy of Zanomaline in Patients with Mild to Moderate Alzheimers Disease.", "", "", "", ""], [48, "CDISCPILOT01", "TS", 1, "", "TPHASE", "Trial Phase Classification", "PHASE II TRIAL", "", "C15601", "CDISC", "2020-03-27"], [49, "CDISCPILOT01", "TS", 1, "", "TRT", "Investigational Therapy or Treatment", "Zanomaline", "", "0XXX0X00XX", "UNII", ""], [50, "CDISCPILOT01", "TS", 1, "", "TTYPE", "Trial Type", "SAFETY", "", "C49667", "CDISC", "2020-03-27"], [51, "CDISCPILOT01", "TS", 2, "", "TTYPE", "Trial Type", "EFFICACY", "", "C49666", "CDISC", "2020-03-27"]]}}}}